EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q3 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
EKSO on Nasdaq
Shares outstanding
29,997,317
Price per share
$0.44
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-15,000
Value change
-$4,530
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% 0% $1,207,683 +$300,925 2,996,732 +33% Armistice Capital, LLC 31 Mar 2025
Kent Lake PR LLC 4.6% $403,000 1,000,000 Kent Lake PR LLC 31 Dec 2024

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO). This represents 0% of the company’s total 29,997,317 outstanding shares.

Institutional Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$4,530 $0.44 0
2025 Q2 15,000 $4,530 -$1,518,996 $0.30 1
2025 Q1 3,785,922 $1,525,045 -$311,398 $0.40 36
2024 Q4 4,039,425 $2,463,897 -$820,496 $0.61 30
2024 Q3 5,345,999 $6,201,410 +$2,781,536 $1.16 27
2024 Q2 1,974,478 $2,083,151 +$330,495 $1.06 27
2024 Q1 1,533,767 $2,085,783 +$379,847 $1.36 35
2023 Q4 1,149,584 $2,873,579 +$154,863 $2.50 32
2023 Q3 1,112,762 $815,320 -$150,149 $0.73 33
2023 Q2 1,317,003 $1,882,936 -$14,711 $1.43 29
2023 Q1 1,324,484 $2,185,060 -$120,979 $1.65 30
2022 Q4 1,404,858 $1,670,877 +$166,636 $1.19 26
2022 Q3 1,273,756 $1,986,168 +$104,198 $1.56 21
2022 Q2 1,203,565 $1,986,178 -$408,720 $1.65 22
2022 Q1 1,436,553 $4,150,312 -$52,060 $2.89 18
2021 Q4 1,462,593 $3,875,610 +$367,944 $2.65 19
2021 Q3 1,270,993 $5,877,063 -$7,986 $4.62 25
2021 Q2 1,271,517 $6,995,594 -$151,026 $5.50 28
2021 Q1 1,284,402 $7,922,728 +$6,084,639 $6.17 30
2020 Q4 295,005 $1,807,662 -$1,822,968 $6.12 13
2020 Q3 1,247,413 $5,915,513 +$557,521 $4.75 16
2020 Q2 1,124,574 $9,418,907 +$815,150 $8.40 18
2020 Q1 1,029,080 $2,915,306 +$2,915,314 $2.84 10